BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28032215)

  • 1. A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma.
    El-Habr EA; Dubois LG; Burel-Vandenbos F; Bogeas A; Lipecka J; Turchi L; Lejeune FX; Coehlo PL; Yamaki T; Wittmann BM; Fareh M; Mahfoudhi E; Janin M; Narayanan A; Morvan-Dubois G; Schmitt C; Verreault M; Oliver L; Sharif A; Pallud J; Devaux B; Puget S; Korkolopoulou P; Varlet P; Ottolenghi C; Plo I; Moura-Neto V; Virolle T; Chneiweiss H; Junier MP
    Acta Neuropathol; 2017 Apr; 133(4):645-660. PubMed ID: 28032215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas.
    Hujber Z; Horváth G; Petővári G; Krencz I; Dankó T; Mészáros K; Rajnai H; Szoboszlai N; Leenders WPJ; Jeney A; Tretter L; Sebestyén A
    J Exp Clin Cancer Res; 2018 Nov; 37(1):271. PubMed ID: 30404651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function.
    Buzzi A; Wu Y; Frantseva MV; Perez Velazquez JL; Cortez MA; Liu CC; Shen LQ; Gibson KM; Snead OC
    Brain Res; 2006 May; 1090(1):15-22. PubMed ID: 16647690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catabolism of GABA, succinic semialdehyde or gamma-hydroxybutyrate through the GABA shunt impair mitochondrial substrate-level phosphorylation.
    Ravasz D; Kacso G; Fodor V; Horvath K; Adam-Vizi V; Chinopoulos C
    Neurochem Int; 2017 Oct; 109():41-53. PubMed ID: 28300620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal glutamine supplementation in murine succinic semialdehyde dehydrogenase deficiency, a disorder of γ-aminobutyric acid metabolism.
    Brown MN; Walters DC; Schmidt MA; Hill J; McConnell A; Jansen EEW; Salomons GS; Arning E; Bottiglieri T; Gibson KM; Roullet JB
    J Inherit Metab Dis; 2019 Sep; 42(5):1030-1039. PubMed ID: 31032972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutants of GABA transaminase (POP2) suppress the severe phenotype of succinic semialdehyde dehydrogenase (ssadh) mutants in Arabidopsis.
    Ludewig F; Hüser A; Fromm H; Beauclair L; Bouché N
    PLoS One; 2008; 3(10):e3383. PubMed ID: 18846220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency.
    Ethofer T; Seeger U; Klose U; Erb M; Kardatzki B; Kraft E; Landwehrmeyer GB; Grodd W; Storch A
    Neurology; 2004 Mar; 62(6):1016-8. PubMed ID: 15037717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSADH deficiency in an Italian family: a novel ALDH5A1 gene mutation affecting the succinic semialdehyde substrate binding site.
    Leo S; Capo C; Ciminelli BM; Iacovelli F; Menduti G; Funghini S; Donati MA; Falconi M; Rossi L; Malaspina P
    Metab Brain Dis; 2017 Oct; 32(5):1383-1388. PubMed ID: 28664505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder.
    Vogel KR; Ainslie GR; McConnell A; Roullet JB; Gibson KM
    Toxicol In Vitro; 2018 Feb; 46():203-212. PubMed ID: 29031482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of blood biomarkers with age informs pathomechanisms in succinic semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.
    Jansen EE; Vogel KR; Salomons GS; Pearl PL; Roullet JB; Gibson KM
    J Inherit Metab Dis; 2016 Nov; 39(6):795-800. PubMed ID: 27686230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development.
    Jansen EE; Struys E; Jakobs C; Hager E; Snead OC; Gibson KM
    BMC Dev Biol; 2008 Nov; 8():112. PubMed ID: 19040727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma Cells Expressing High Levels of ALDH5A1 Exhibit Enhanced Migration Transcriptional Signature in Patient Tumors.
    Piperi C; Saurty-Seerunghen MS; Levidou G; Sepsa A; Trigka EA; Klonou A; Markouli M; Strepkos D; Spyropoulou A; Kanakoglou DS; Lakiotaki E; Karatrasoglou EA; Boviatsis E; El-Habr EA; Korkolopoulou P
    Neurotherapeutics; 2023 Apr; 20(3):881-895. PubMed ID: 36976494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous gamma-hydroxybutyrate in rat brain areas: postmortem changes and effects of drugs interfering with gamma-aminobutyric acid metabolism.
    Eli M; Cattabeni F
    J Neurochem; 1983 Aug; 41(2):524-30. PubMed ID: 6875551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered cerebral glucose and acetate metabolism in succinic semialdehyde dehydrogenase-deficient mice: evidence for glial dysfunction and reduced glutamate/glutamine cycling.
    Chowdhury GM; Gupta M; Gibson KM; Patel AB; Behar KL
    J Neurochem; 2007 Dec; 103(5):2077-91. PubMed ID: 17854388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Molecular Mechanisms of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): Towards the Development of SSADH-Targeted Medicine.
    Lee HHC; McGinty GE; Pearl PL; Rotenberg A
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic and metabolic evidence for a region specific mitochondrial dysfunction in brains of murine succinic semialdehyde dehydrogenase deficiency (Aldh5a1-/- mice).
    Sauer SW; Kölker S; Hoffmann GF; Ten Brink HJ; Jakobs C; Gibson KM; Okun JG
    Neurochem Int; 2007 Mar; 50(4):653-9. PubMed ID: 17303287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the participation of a cytosolic NADP+-dependent oxidoreductase in the catabolism of gamma-hydroxybutyrate in vivo.
    Kaufman EE; Nelson T
    J Neurochem; 1987 Jun; 48(6):1935-41. PubMed ID: 3106576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of ABCG2 in human malignant glioma].
    Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
    Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency.
    Malaspina P; Picklo MJ; Jakobs C; Snead OC; Gibson KM
    Hum Genomics; 2009 Jan; 3(2):106-20. PubMed ID: 19164088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism.
    Gibson KM; Hoffmann GF; Hodson AK; Bottiglieri T; Jakobs C
    Neuropediatrics; 1998 Feb; 29(1):14-22. PubMed ID: 9553943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.